Episode Details

Back to Episodes
231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market

231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market

Published 4 years ago
Description
Lawyer and bioethicist ​​Holly Fernandez Lynch joins us to explain a watershed test of the FDA's authority to revoke drug approvals. And STAT's Helen Branswell calls in to discuss the headline-grabbing research at Boston University involving a lab-developed version of the virus that causes Covid-19.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us